Hemostemix Inc. Share Price
Stocks
HEM
CA4236943060
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Toronto S.E.
09:10:34 27/08/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 0.0800 CAD | +6.67% |
|
0.00% | -11.11% |
| 20/08 | Hemostemix Commercializes Its Vascular Dementia Clinical Trial of Vescell(Tm) Under Larta | CI |
| 31/07 | Hemostemix Raises C$322,250 From Second Tranche of Private Placement | MT |
| Market Cap | 1.58Cr 1.14Cr 98L 91.75L 84.01L 109.03Cr 1.59Cr 11Cr 4.25Cr 55Cr 4.29Cr 4.19Cr 181.87Cr | P/E 2024 |
-4.36x | P/E 2025 | -3.12x |
|---|---|---|---|---|---|
| Enterprise Value | 1.87Cr 1.35Cr 1.16Cr 1.08Cr 99.2L 128.74Cr 1.87Cr 13Cr 5.01Cr 65Cr 5.06Cr 4.95Cr 214.74Cr | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
82.85% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +6.67% | ||
| Current month | +33.33% | ||
| 1 month | +33.33% | ||
| 3 months | +45.45% | ||
| 6 months | -5.88% | ||
| Current year | -11.11% |
| 1 week | 0.07 |  | 0.08 |
| 1 month | 0.06 | | 0.08 |
| Current year | 0.04 | | 0.11 |
| 1 year | 0.04 | | 0.14 |
| 3 years | 0.04 | | 0.42 |
| 5 years | 0.04 | | 0.42 |
| 10 years | 0 | | 5.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Smeenk
CEO | Chief Executive Officer | - | 10/02/2020 |
Christina Wu
DFI | Director of Finance/CFO | - | 05/03/2020 |
Fraser Henderson
CTO | Chief Tech/Sci/R&D Officer | - | 14/10/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Thomas Smeenk
BRD | Director/Board Member | - | 26/11/2019 |
Ronnie Hershmann
BRD | Director/Board Member | 67 | 09/02/2020 |
Loran Swanberg
BRD | Director/Board Member | - | 08/04/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 30/07/26 | Option | Chairman | 5,25,000 | 0.2654% | ||
| 22/07/26 | Option | Director | 3,85,000 | 0.1946% | ||
| 22/07/26 | Option | Founder | 17,30,000 | 0.8746% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +6.67% | 0.00% | 0.00% | -33.33% | 1.14Cr | |
| +3.31% | -3.70% | +61.03% | +103.64% | 7.06TCr | |
| -0.22% | +0.38% | +50.25% | +92.80% | 6.61TCr | |
| -1.03% | +0.46% | +8.14% | -5.28% | 2.8TCr | |
| -2.41% | -2.95% | -9.77% | +455.82% | 2.65TCr | |
| +0.30% | -0.69% | +63.18% | +11.93% | 2.64TCr | |
| +1.02% | +6.43% | +269.42% | +420.34% | 2.04TCr | |
| +0.51% | +1.39% | +35.26% | -17.07% | 2.02TCr | |
| -1.91% | -4.37% | +13.33% | +531.29% | 1.6TCr | |
| -1.50% | +2.92% | +43.50% | +151.30% | 1.37TCr | |
| Average | +0.47% | +0.89% | +53.43% | +171.14% | 2.88TCr | |
| Weighted average by Cap. | +0.40% | +0.65% | +56.57% | +154.57% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -26.16L -18.87L -16.2L -15.17L -13.89L -18Cr -26.24L -1.8Cr -70.21L -9.08Cr -70.86L -69.33L -30Cr | -47.14L -34L -29.19L -27.33L -25.02L -32Cr -47.27L -3.24Cr -1.26Cr -16Cr -1.28Cr -1.25Cr -54Cr |
| Net Debt | 42.31L 30.52L 26.2L 24.53L 22.46L 29Cr 42.43L 2.9Cr 1.14Cr 15Cr 1.15Cr 1.12Cr 49Cr | 28.61L 20.64L 17.71L 16.59L 15.19L 20Cr 28.69L 1.96Cr 76.77L 9.93Cr 77.48L 75.81L 33Cr |
Employees
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 27/26/27 | CA$0.0800 | +6.67% | 59,001 |
| 26/26/26 | CA$0.0750 | +7.14% | 1,912 |
| 25/26/25 | CA$0.0700 | -6.67% | 1,300 |
| 24/26/24 | CA$0.0750 | 0.00% | 1,13,267 |
| 21/26/21 | CA$0.0750 | -6.25% | 5,629 |
- Stock Market
- Stocks
- HEM Stock
Select your edition
All financial news and data tailored to specific country editions
